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Ascorbic acid prevents cimetidine-induced decrease of serum 
hydrocortisone concentrations 
Mar inus  P. Boidin, Ar ie  S tuurman and Wi lhelm Erdmann 
Int roduct ion 
Cimetidine (Tagamet | Smith Kline & French, 
Rijswijk, the Netherlands) is a major histamine 
H 2 receptor antagonist. Intravenously, it has 
been advocated in critical and intensive-care 
medicine for the prevention of stress ulcers. Few 
side-effects of clinical importance, apart from 
gynaecomastia, have been reported [1]. Anti- 
androgenic effects of cimetidine have been re- 
ported [2]. Recently, it has been reported that 
cimetidine can decrease serum hydrocortisone 
concentrations in man [3]. 
Imidazoles, cimetidine, and etomidate 
(Hypnomidate | Janssen, Beerse, Belgium), can 
bind to cytochrome P-450 at the active haem 
structure [4 5]. This causes a blockade of the cyto- 
chrome with a concomitant decrease of the 
serum hydrocortisone concentrations. Cyto- 
chrome P-450 proves to be essential for the 20-22 
hydroxylation of cholesterol, the precursor for 
many steroid hormones [6]. Administration of 
cimetidine may result in low serum hydrocorti- 
sone concentrations. Intravenous administration 
of ascorbic acid is supposed to protect he serum 
hydrocortisone concentrations in patients whose 
steroid synthesis is inhibited by imidazoles [7]. 
The reason for ~ this phenomenon is yet undeter- 
mined. 
This prospective, blind, parallel study was de- 
signed to establish the effect of ascorbic acid on 
human hydrocortisone concentrations after cime- 
tidine administration. 
Methods 
20 Consecutive male patients entered this 
study. Any patients uffering from renal, hepatic 
or endocrinological diseases and patients using 
corticosteroid drugs, H 2 antagonists or any other 
imidazole including drug, in a period of four 
weeks prior to surgery, were excluded from the 
study population. Patients with incomplete data, 
because of short duration of surgery, were omit- 
ted. Patients receiving fresh frozen plasma were 
excluded from the study population. After ex- 
clusion for these criteria, 16 patients remained. 
These patients were randomly devided into two 
groups for a parallel-blind investigation. 
All patients were scheduled for major abdomi- 
nal vascular surgery lasting longer than 3.5 h. 
The study procedure and conditions were kept as 
uniform as possible. All procedures were sched- 
uled for 08.00 and followed the same course 
during the morning. All patients needed in- 
vasive monitoring and intensive care postoperat- 
ively during 24 h. Informed consent was obtained 
from all patients the day before surgery and the 
study was in accordance with the standards of 
the hospital ethical committee, which bases it de- 
cisions on the Helsinki Declaration. 
An epidural catheter was inserted between the 
third and fourth vertebra on the day prior to sur- 
gery. No premedication was given. Anaesthesia 
was induced with methohexital  1 mg/kg 
(Brietal | Lilly, Nieuwegein, the Netherlands), 
pir itramide 0.2 mg/kg (Dipidolor | Janssen) and 
pancuronium bromide 1 mg/kg (Pavulon | Orga- 
non, Oss, the Netherlands). Patients were venti- 
lated throughout the surgical procedure. Bupiva- 
caine 0.1 ml/kg (Marcaine | Astra, Rijswijk, the 
Netherlands) was administered via the epidural 
catheter at the time of induction. The radial ar- 
tery  and the subclavian vein were cannulated. 
This induction period lasted for approximately 
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Abstract 
A blind, parallel, prospective, clinical study was conducted to investigate he effect of 
ascorbic acid on human serum hydrocortisone concentrations which were decreased by the 
administration f cimetidine. The study population included 16 male adults scheduled for 
major abdominal vascular surgery. The study was conducted in surgical patients under 
anaesthesia, in which steroidogenesis was inhibited by cimetidine. The results howed a 
reduction in serum hydrocortisone concentrations in patients receiving a placebo. In patients 
receiving ascorbic acid, there was a significant increase in serum hydrocortisone 
concentration. This reflects the normal serum hydrocortisone profile for this operation and 
anaesthetic technique. Cimetidine can bind to cytochrome P-450 covering the active haem 
group, the cytochrome proves to be of vital importance for hydroxylation reactions, involved 
in human steroidogenesis. Serum hydrocortisone concentrations will decrease when 
cytochrome P-450 becomes blocked. Intravenous administration f ascorbic acid was supposed 
to cause relief for this decrease. The reasons are undetermined yet. This investigation 
proved that ascorbic acid can prevent cimetidine-induced decrease of human serum 
hydrocortisone concentrations. 
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Table 1 
Demographic data o f  the study populat ion 
Group A B C 
Drugs cimetidine cimetidine with control 
with placebo ascorbic acid group 
Patients 8 8 8 
Age (years) (SD) 65 (8.1) 68 (9.1) 66 (7.3) 
Weight (kg) (SD) 73 (9.1) 72 (9.6) 74 (9.3) 
Surgery (h) 5.7 (4.2-7.3) 6.3 (5.2-8.2) 5.5 (4.5-6.6) 






A: black) and 











*: P < 0.01 
anaesthetic technique is exactly known. The 
values of this historic control group, which were 
recorded in the same settings and in the same 
laboratories, were Considered sufficiently reliable 
to serve as the control values for this study. 
Physiological parameters, electrocardiogram, 
arterial systolic and diastolic blood pressures, 
central-venous mean pressure, heart rate, core 
temperature and urinary output, were monitored 
continuously. Blood, plasma expanders and 
electrolyte solutions for intravenous infusion, 
were administered as appropriate. Cloxacillin 
1000 mg (Orbenin | Beecham, Amstelveen, the 
Netherlands) was given intravenously to all 
patients, as a prophylactic antibiotic. No cortico- 
steroid or any other drugs were given, except 
analgesics and muscle relaxants necessary for 
the maintenance of anaesthesia. Serum samples 
were taken before induction of anaesthesia and 
at 60, 120 and 180 min after cimetidine admin- 
istration. All samples were immediately stored 
on ice, centrifuged and frozen as soon as possible. 
After collection of the samples, all patients re- 
ceived 1000 mg fresh ascorbic acid intra- 
venously. 











t Cimetidine 400 mg T 
3 hours 
400 mg Of cimetidine was given as a slow in- 
travenous bolus injection at the end of the induc- 
tion of anaesthesia. In the contralateral arm a 
continuous drip infusion of 100 ml saline was 
started with either 10 ml of saline as a placebo 
(group A) or 10 ml fluid with 1000 mg of ascorbic 
acid (group B). The drip ran at twelve drops/min 
via an infusion pump (IVAC 300). This resulted 
in the administration of 100 ml fluid over 3 h. 
The administration code, registered in the hospi- 
tal pharmacy department, could be obtained 
when necessary for clinical reasons. 
Measurement of serum hydrocortisone concen- 
tration was made with the Coat-A-Count RIA Kit 
(Diagnostic Products Corporation, Los Angeles, 
USA). Within-run precision in the normal range 
(150-550 nmol/1) is 4%. Interassay precision in 
the same range is 8%. The least detectable l vel 
is 5 nmol/1. There is 65% cross-reactivity with 
prednisolone. Neither severe icterus, gross hae- 
molysis, nor severe lipaemia have any effect on 
the procedure. 
Mean values of samples taken at 60, 120 and 
180 min in each group were compared with the 
pre-operative alue. Statistical differences of the 
mean values were calculated with the one way 
analysis of variance [8]. 
Results 
The two groups of 8 patients were comparable 
for demographic data (Table 1). Physiologic par- 
ameters in both groups showed no different mean 
values during anaesthesia. Arterial systolic, 
diastolic and mean pressures, central venous 
blood pressure, urine output and temperature 
showed essentially the same values in both 
groups. There were no major clinical differences 
between the two groups during the first 4 h of 
surgery. 
In group A (placebo) there was a gradual de- 
crease in serum hydrocortisone concentration. 
3 Out of 8 patients reached levels beyond the low 
normal values. 7 Patients showed a decrease in 
serum hydrocortisone levels ranging from 0-60%. 
1 Patient, however, showed a 30% increase in se- 
rum hydrocortisone concentration (Fig. 1). 
In group B (ascorbic acid) there was a gradual 
increase of the serum hydrocortisone concen- 
trations in the time. The increase is significant 
from the second hour until the end of the study 
period. All patients howed increased serum hy- 
drocortisone l vels ranging from 15 to just over 
100%. Intergroup comparison demonstrated sig- 
nificant (P < 0.001) lower values in group A (pla- 
cebo) when compared to group B (ascorbic acid). 
Discuss ion 
The moderate but significant increase in serum 
hydrocortisone concentrations i in accordance 
with the findings of Oyama and Takiguchi repor- 
ting on patients under spinal anaesthesia [9]. 
The normal hydrocortisone profile of this oper- 
ation and anaesthetic technique in our hospital 
shows a slow but graduate increase of the serum 
hydrocortisone concentrations. The increase of 
the mean value proved to be from 56 nmol/1-1 to 
97 nmol/1-1 after 3 h. 
Administration of ascorbic acid appears to 
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have a protective ffect on the serum hydrocorti- 
sone concentrations of patients who have re- 
ceived cimetidine intravenously. The reason for 
this phenomenon is not determined yet. The re- 
sults of this study confirm the observations in 
previous tudies. The serum hydrocortisone con- 
centrations are comparable with the normal hy- 
drocortisone profile for this operation and anaes- 
thetic technique. 
According to the manufacturer of cimetidine 
[Smith Kline & French, personal communi- 
Cation], no long-term animal studies have been 
performed to investigate the effects of cimetidine 
on serum hydrocortisone concentrations. Carlson 
and Ippoliti [10] found no negative ffects on ster- 
oidogenesis in patients receiving cimetidine. 
Feely et al. [11] reported ecreased levels of corti- 
costeroid degradation products and aldosterone 
in the urine of patients receiving cimetidine. 
Kenyon et al. [12] published an in vitro study on 
the various effects of cimetidine and ranitidine 
(Zantac | Glaxo, Nieuwegein, the Netherlands) 
in isolated bovine adrenal cells. Cimetidine con- 
centrations greater than 200 ~g/ml resulted in a 
50% inhibition of hydrocortisone synthesis. With 
ranitidine, this effect only became apparent at 
2000 ~g/ml. De Natale et al. [13] suggested that 
bolus injections of cimetidine could temporarily 
suppress normal corticosteroid production. Re- 
cent evidence shows that cimetidine can block 
steroid synthesis in man [3]. In a double-blind 
study it was demonstrated that cimetidine de: 
creased serum hydrocortisone concentrations. 
The same effect could not be demonstrated with 
ranitidine. This effect has only been observed in 
anaesthesia; probably because the feedback 
mechanism is blunted by the anaesthetic tech- 
nique. Because of the anaesthetic technique, 
hydrocortisone is not increased by neurological 
stimuli caused by pain and surgical stress or 
awakeness. 
It has been shown that ascorbic acid can 
restore the hydrocortisone synthesis in case of 
hypnomidate toxicity [14]. Also in the case of 
cimetidine toxicity there was a restoration of the 
serum hydrocortisone concentration after admin- 
istration of ascorbic acid [3]. The mechanism is
presently under investigation. Hornsby looked at 
the ll-beta-hydroxylase activity [15]. He sug- 
gested that ascorbic acid is a protective com- 
pound for cytochrome because 5 mM ascorbate 
prevented the rate of loss of 11-beta-hydroxylase 
activity in the presence of hydrocortisone. But no 
fitting explanation has been suggested at pre- 
sent. 
The question remains as to whether or not 
these results have any clinical consequences. In 
the opinion of the authors it is highly probable 
that they have. Malnourished and postoperative 
patients, or patients for any reason treated solely 
with dextrose or electrolyte-containing fusion 
fluids, run a high risk of catching an illness 
when cimetidine is prescribed. Without proper 
substitution of ascorbic acid the possibility exists 
that an acute addisonian crisis may develop. 
Such a situation has been reported in the case of 
administration of etomidate [16]. 
Conclusions 
Ascorbic acid appears to increase the serum hy- 
drocortisone concentrations in patients under 
anaesthesia, when the steroidogenesis in- 
hibited by cimetidine. It is unclear from the pre- 
sented data what the clinical implication will be 
for these patients. 
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